Mitsubishi UFJ Kokusai Asset Management Co. Ltd. reduced its stake in shares of Aetna Inc (NYSE:AET) by 1.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 50,628 shares of the company’s stock after selling 506 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Aetna were worth $9,204,000 at the end of the most recent reporting period.
Several other institutional investors also recently added to or reduced their stakes in AET. Orbimed Advisors LLC boosted its holdings in Aetna by 57.3% in the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock valued at $222,057,000 after purchasing an additional 508,600 shares during the period. CI Investments Inc. purchased a new stake in shares of Aetna during the 4th quarter valued at $87,552,000. Point72 Asset Management L.P. raised its position in shares of Aetna by 233.9% during the 3rd quarter. Point72 Asset Management L.P. now owns 429,353 shares of the company’s stock valued at $68,271,000 after buying an additional 300,753 shares in the last quarter. Ardevora Asset Management LLP purchased a new stake in shares of Aetna during the 3rd quarter valued at $35,507,000. Finally, Milestone Resources Group Ltd purchased a new stake in shares of Aetna during the 4th quarter valued at $35,385,000. 87.10% of the stock is owned by hedge funds and other institutional investors.
Shares of Aetna Inc (AET) traded down $1.16 during trading on Wednesday, reaching $177.36. 995,924 shares of the company’s stock traded hands, compared to its average volume of 2,910,715. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.68 and a quick ratio of 0.53. Aetna Inc has a twelve month low of $124.83 and a twelve month high of $194.40. The stock has a market capitalization of $57,993.06, a PE ratio of 31.00, a PEG ratio of 1.44 and a beta of 0.60.
Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The firm had revenue of $14.74 billion during the quarter, compared to analysts’ expectations of $14.79 billion. During the same period in the previous year, the company earned $0.08 earnings per share. The firm’s quarterly revenue was down 6.2% on a year-over-year basis. research analysts forecast that Aetna Inc will post 10.99 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, January 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.13%. Aetna’s payout ratio is 34.78%.
A number of equities analysts recently commented on AET shares. BMO Capital Markets lifted their target price on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research report on Friday, October 27th. Morgan Stanley cut shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price on the stock. in a research report on Wednesday, December 20th. Cantor Fitzgerald cut shares of Aetna from an “overweight” rating to a “neutral” rating in a research report on Thursday, October 26th. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “strong-buy” rating and set a $184.00 price objective on the stock in a research report on Wednesday, October 25th. Finally, Credit Suisse Group restated a “neutral” rating and issued a $195.00 price objective (up previously from $174.00) on shares of Aetna in a research report on Wednesday, December 6th. Ten research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $185.94.
TRADEMARK VIOLATION WARNING: This article was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.dispatchtribunal.com/2018/02/14/mitsubishi-ufj-kokusai-asset-management-co-ltd-sells-506-shares-of-aetna-inc-aet.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.